Home Home Contact Us Help Registering and Participating Disclaimer Please Note: THIS FORUM IS PATIENT MODERATED AND IS NOT CONNECTED TO ANY CLINIC OR DOCTOR. IF YOU WISH TO CONTACT A CERTAIN DOCTOR OR CLINIC, PLEASE LOOK IN THE ASK THE DOCTOR SECTION FOR DOCTOR OR CLINIC PHONE NUMBERS AND EMAIL ADDRESSES.

                       Home || Contact Us || Help Registering and Participating || Disclaimer

Unlock Secrets in Your Own DNA with 23andMe.com

Nutri-Health Products

 Buy 1 Get 1 Free at Puritan's Pride

LivLong – The Ultimate Anti-aging Product

SeaChange Partners with Life Extension Products

 

Barbara and Jeannine's Book

Bea Luis Memorial

 

Join the ICMS


Go Back   Stem Cell Pioneers > Diseases / Stem Cell Treatments > General Stem Cell Discussion
Register Blogs FAQ Members List Social Groups Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Search this Thread Display Modes
  #1  
Old 07-14-2012, 04:14 PM
yorkere yorkere is offline
Senior Member
 
Join Date: Jan 2008
Location: Riverside, CA
Posts: 237
Default Regenerative Sciences Receives $2M Investment

Hey!

Take a look:

http://www.marketwatch.com/story/reg...ves-2012-05-14

This funding for them should be of huge help to them (and us!)

Robert


DENVER, May 14, 2012 /PRNewswire via COMTEX/ -- Regenerative Sciences, Inc., a company dedicated to advancing orthopedic care through non-surgical adult stem cell procedures, today announced that it has secured a $2M investment from philanthropist, visionary and businessman John C. Malone, PhD, chairman of Liberty Media Corporation. In addition to advancing Regenerative Sciences' clinical and lab-based stem cell research, the investment will help support the national expansion of their Regenexx(TM) Physician Network.

Regenerative Sciences' Regenexx procedures utilize a patient's own stem cells to help repair a broad range of common injuries and degenerative conditions, including cartilage lesions, torn ligaments and tendons, osteoarthritis and bulging spinal discs. For many, the procedures offer a viable alternative to arthroscopic surgery, open-joint surgery, or joint replacement surgery. Regenexx patients experience little or no downtime from the procedures and avoid the lengthy rehabilitation period associated with most surgical procedures.

"We are proud of our accomplishments in the field of regenerative interventional orthopedics and it's exciting that our work has drawn the attention of such a noted entrepreneur and philanthropist," said Christopher J. Centeno, M.D., Chief Executive Officer of Regenerative Sciences. "Dr. Malone shares our vision for forging the next generation of minimally invasive regenerative treatments. This investment will not only bolster our existing stem cell research programs and make our procedures available in all regions of the U.S., but it will help us maintain a leadership role in clarifying the regulatory space for physician stem cell use."

Regenerative Sciences is at the forefront of regenerative orthopedic medicine within the United States and the company is bringing the future of orthopedic treatments to patient care today.

About Regenerative Sciences

Regenerative Sciences is an outgrowth of the Centeno-Schultz clinic, where we are reinventing orthopedic care for the 21st century using key biologics such as stem cells, next generation tools and devices, and unique therapeutic approaches. Our signature initiative, Interventional Orthopedics, allows doctors to treat orthopedic conditions through injection, rather than traditional invasive surgery. The Regenexx Physician Network brings together like-minded physicians from around the country to offer more patients access to our innovative procedures. For more information on Regenerative Sciences and Regenexx procedures, visit: www.regenexx.com

About John C. Malone, PhD

Dr. John C. Malone holds a bachelor's degree in electrical engineering and economics from Yale University, where he was a Phi Beta Kappa and merit scholar. He also holds a master's degree in industrial management and a Ph.D. in operations research from Johns Hopkins University.

Dr. Malone is Chairman of Liberty Media Corporation, a position he has held since 1990. Dr. Malone is also the Chairman of the Board of Liberty Global, Inc. (LGI), a position he has held since June, 2005. From 1996 to March 1999 when Tele-Communications, Inc. (TCI) merged with AT&T Corp., he was also Chairman and Chief Executive Officer of TCI. Previous to that, from 1973 to 1996, Dr. Malone served as President and CEO of TCI. He currently serves on the Board of Directors for CATO Institute, Expedia, Inc., Discovery Communications, Inc., and SiriusXM.
Reply With Quote
  #2  
Old 07-15-2012, 11:33 AM
barbara barbara is offline
Pioneer Founding member
 
Join Date: May 2007
Posts: 6,905
Blog Entries: 5
Default

Dr. Centeno was elated with this news. I think it is a positive sign for the future of adult stem cell therapy that investments like this are happening.
__________________
First treatment in 2007. Pioneering ever since.

Barbara
Reply With Quote
  #3  
Old 07-15-2012, 12:34 PM
yorkere yorkere is offline
Senior Member
 
Join Date: Jan 2008
Location: Riverside, CA
Posts: 237
Default

Do we have any updated status regarding this court case...I assume it's still ongoing...?

Robert
Reply With Quote
  #4  
Old 07-15-2012, 01:29 PM
barbara barbara is offline
Pioneer Founding member
 
Join Date: May 2007
Posts: 6,905
Blog Entries: 5
Default

No news yet I'm afraid.
__________________
First treatment in 2007. Pioneering ever since.

Barbara
Reply With Quote
Reply

Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is Off
HTML code is Off

Forum Jump

Copyright 2007 - 2011 Stem Cell Pioneers


All times are GMT -6. The time now is 12:14 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2013, vBulletin Solutions, Inc.
Stem Cell Pioneers